{"id":7339,"date":"2021-01-19T20:21:49","date_gmt":"2021-01-20T01:21:49","guid":{"rendered":"https:\/\/www.millerthomson.com\/deals-cases\/theratechnologies-conclut-un-placement-par-voie-de-prise-ferme-dune-valeur-de-46-millions-de-dollars-americains\/"},"modified":"2026-01-20T17:38:04","modified_gmt":"2026-01-20T22:38:04","slug":"theratechnologies-conclut-un-placement-par-voie-de-prise-ferme-dune-valeur-de-46-millions-de-dollars-americains","status":"publish","type":"deals-cases","link":"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/theratechnologies-conclut-un-placement-par-voie-de-prise-ferme-dune-valeur-de-46-millions-de-dollars-americains\/","title":{"rendered":"Theratechnologies conclut un placement par voie de prise ferme d\u2019une valeur de 46 millions de dollars am\u00e9ricains"},"content":{"rendered":"

Le 19\u00a0janvier\u00a02021, Theratechnologies Inc. (TSX:TH; NASDAQ:THTX) (\u00ab\u00a0Theratechnologies\u00a0\u00bb), une soci\u00e9t\u00e9 biopharmaceutique sp\u00e9cialis\u00e9e dans le d\u00e9veloppement et la commercialisation de th\u00e9rapies novatrices, a annonc\u00e9 la cl\u00f4ture d\u2019un placement public par voie de prise ferme (le \u00ab\u00a0placement\u00a0\u00bb), en vertu duquel Theratechnologies a \u00e9mis 16\u00a0727\u00a0900 unit\u00e9s (les \u00ab\u00a0unit\u00e9s\u00a0\u00bb) \u00e0 un prix de 2,75\u00a0$ US par unit\u00e9 (ou environ 3,51\u00a0$ CA par unit\u00e9s) (le \u00ab\u00a0prix des unit\u00e9s\u00a0\u00bb) pour un produit total brut de 46\u00a0001\u00a0725\u00a0$\u00a0US (ou environ 58\u00a0714\u00a0929\u00a0$\u00a0CA), y compris l\u2019exercice int\u00e9gral de l\u2019option d\u2019attribution exc\u00e9dentaire pour l\u2019achat de 2\u00a0181\u00a0900\u00a0unit\u00e9s additionnelles au prix des unit\u00e9s.<\/p>\n

Chaque unit\u00e9 est compos\u00e9e d\u2019une action ordinaire de la soci\u00e9t\u00e9 (une \u00ab\u00a0action ordinaire\u00a0\u00bb) et de la moiti\u00e9 d\u2019un bon de souscription d\u2019achat d\u2019action ordinaire de la soci\u00e9t\u00e9 (chaque bon de souscription entier constituant un \u00ab\u00a0bon de souscription\u00a0\u00bb). Chaque bon de souscription permet \u00e0 son porteur d\u2019acqu\u00e9rir une action ordinaire \u00e0 un prix d\u2019exercice de 3,18\u00a0$ US (ou environ 4,06\u00a0$ CA) en tout temps jusqu\u2019au 19\u00a0janvier\u00a02024.<\/p>\n

Le placement \u00e9tait dirig\u00e9 par Mackie Research Capital Corporation, chef de file et unique teneur de livres, qui agissait au nom d\u2019un syndicat de preneurs fermes compos\u00e9 de Canaccord Genuity Corp. et de Financi\u00e8re Banque Nationale Inc.<\/p>\n

L\u2019\u00e9quipe de Miller Thomson qui a conseill\u00e9 le syndicat de preneurs fermes dans le cadre de cette transaction \u00e9tait compos\u00e9e de Geoff Clarke, Jonathan Tong, Brandon Meyer (valeurs mobili\u00e8res); et Karen Durell (propri\u00e9t\u00e9 intellectuelle).<\/p>\n","protected":false},"author":1,"template":"","class_list":["post-7339","deals-cases","type-deals-cases","status-publish","hentry"],"acf":[],"yoast_head":"\nTheratechnologies conclut un placement par voie de prise ferme d\u2019une valeur de 46 millions de dollars am\u00e9ricains | Miller Thomson<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/theratechnologies-conclut-un-placement-par-voie-de-prise-ferme-dune-valeur-de-46-millions-de-dollars-americains\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Theratechnologies conclut un placement par voie de prise ferme d\u2019une valeur de 46 millions de dollars am\u00e9ricains | Miller Thomson\" \/>\n<meta property=\"og:description\" content=\"Conseiller juridique d\u00e2\u20ac\u2122un syndicat de preneurs fermes dirig\u00c3\u00a9 par Mackie Research Capital Corporation\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/theratechnologies-conclut-un-placement-par-voie-de-prise-ferme-dune-valeur-de-46-millions-de-dollars-americains\/\" \/>\n<meta property=\"og:site_name\" content=\"Miller Thomson\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/MillerThomsonLaw\/\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-20T22:38:04+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@millerthomson\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/theratechnologies-conclut-un-placement-par-voie-de-prise-ferme-dune-valeur-de-46-millions-de-dollars-americains\/\",\"url\":\"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/theratechnologies-conclut-un-placement-par-voie-de-prise-ferme-dune-valeur-de-46-millions-de-dollars-americains\/\",\"name\":\"Theratechnologies conclut un placement par voie de prise ferme d\u2019une valeur de 46 millions de dollars am\u00e9ricains | Miller Thomson\",\"isPartOf\":{\"@id\":\"https:\/\/www.millerthomson.com\/fr\/#website\"},\"datePublished\":\"2021-01-20T01:21:49+00:00\",\"dateModified\":\"2026-01-20T22:38:04+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/theratechnologies-conclut-un-placement-par-voie-de-prise-ferme-dune-valeur-de-46-millions-de-dollars-americains\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/theratechnologies-conclut-un-placement-par-voie-de-prise-ferme-dune-valeur-de-46-millions-de-dollars-americains\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/theratechnologies-conclut-un-placement-par-voie-de-prise-ferme-dune-valeur-de-46-millions-de-dollars-americains\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.millerthomson.com\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Transactions et mandats\",\"item\":\"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Theratechnologies conclut un placement par voie de prise ferme d\u2019une valeur de 46 millions de dollars am\u00e9ricains\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.millerthomson.com\/fr\/#website\",\"url\":\"https:\/\/www.millerthomson.com\/fr\/\",\"name\":\"Miller Thomson | Cabinet de droit des affaires pancanadien\",\"description\":\"National law firm providing business law expertise and litigation and disputes services for businesses across Canada since 1957.\",\"publisher\":{\"@id\":\"https:\/\/www.millerthomson.com\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.millerthomson.com\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.millerthomson.com\/fr\/#organization\",\"name\":\"Miller Thomson | Cabinet de droit des affaires pancanadien\",\"url\":\"https:\/\/www.millerthomson.com\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.millerthomson.com\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.millerthomson.com\/wp-content\/uploads\/2024\/10\/miller-thomson.svg\",\"contentUrl\":\"https:\/\/www.millerthomson.com\/wp-content\/uploads\/2024\/10\/miller-thomson.svg\",\"width\":380,\"height\":50,\"caption\":\"Miller Thomson | Cabinet de droit des affaires pancanadien\"},\"image\":{\"@id\":\"https:\/\/www.millerthomson.com\/fr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/MillerThomsonLaw\/\",\"https:\/\/x.com\/millerthomson\",\"https:\/\/www.linkedin.com\/company\/miller-thomson-llp\/\",\"https:\/\/www.youtube.com\/@millerthomson\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Theratechnologies conclut un placement par voie de prise ferme d\u2019une valeur de 46 millions de dollars am\u00e9ricains | Miller Thomson","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/theratechnologies-conclut-un-placement-par-voie-de-prise-ferme-dune-valeur-de-46-millions-de-dollars-americains\/","og_locale":"fr_FR","og_type":"article","og_title":"Theratechnologies conclut un placement par voie de prise ferme d\u2019une valeur de 46 millions de dollars am\u00e9ricains | Miller Thomson","og_description":"Conseiller juridique d\u00e2\u20ac\u2122un syndicat de preneurs fermes dirig\u00c3\u00a9 par Mackie Research Capital Corporation","og_url":"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/theratechnologies-conclut-un-placement-par-voie-de-prise-ferme-dune-valeur-de-46-millions-de-dollars-americains\/","og_site_name":"Miller Thomson","article_publisher":"https:\/\/www.facebook.com\/MillerThomsonLaw\/","article_modified_time":"2026-01-20T22:38:04+00:00","twitter_card":"summary_large_image","twitter_site":"@millerthomson","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/theratechnologies-conclut-un-placement-par-voie-de-prise-ferme-dune-valeur-de-46-millions-de-dollars-americains\/","url":"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/theratechnologies-conclut-un-placement-par-voie-de-prise-ferme-dune-valeur-de-46-millions-de-dollars-americains\/","name":"Theratechnologies conclut un placement par voie de prise ferme d\u2019une valeur de 46 millions de dollars am\u00e9ricains | Miller Thomson","isPartOf":{"@id":"https:\/\/www.millerthomson.com\/fr\/#website"},"datePublished":"2021-01-20T01:21:49+00:00","dateModified":"2026-01-20T22:38:04+00:00","breadcrumb":{"@id":"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/theratechnologies-conclut-un-placement-par-voie-de-prise-ferme-dune-valeur-de-46-millions-de-dollars-americains\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/theratechnologies-conclut-un-placement-par-voie-de-prise-ferme-dune-valeur-de-46-millions-de-dollars-americains\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/theratechnologies-conclut-un-placement-par-voie-de-prise-ferme-dune-valeur-de-46-millions-de-dollars-americains\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.millerthomson.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Transactions et mandats","item":"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/"},{"@type":"ListItem","position":3,"name":"Theratechnologies conclut un placement par voie de prise ferme d\u2019une valeur de 46 millions de dollars am\u00e9ricains"}]},{"@type":"WebSite","@id":"https:\/\/www.millerthomson.com\/fr\/#website","url":"https:\/\/www.millerthomson.com\/fr\/","name":"Miller Thomson | Cabinet de droit des affaires pancanadien","description":"National law firm providing business law expertise and litigation and disputes services for businesses across Canada since 1957.","publisher":{"@id":"https:\/\/www.millerthomson.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.millerthomson.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.millerthomson.com\/fr\/#organization","name":"Miller Thomson | Cabinet de droit des affaires pancanadien","url":"https:\/\/www.millerthomson.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.millerthomson.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.millerthomson.com\/wp-content\/uploads\/2024\/10\/miller-thomson.svg","contentUrl":"https:\/\/www.millerthomson.com\/wp-content\/uploads\/2024\/10\/miller-thomson.svg","width":380,"height":50,"caption":"Miller Thomson | Cabinet de droit des affaires pancanadien"},"image":{"@id":"https:\/\/www.millerthomson.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/MillerThomsonLaw\/","https:\/\/x.com\/millerthomson","https:\/\/www.linkedin.com\/company\/miller-thomson-llp\/","https:\/\/www.youtube.com\/@millerthomson"]}]}},"_links":{"self":[{"href":"https:\/\/www.millerthomson.com\/fr\/wp-json\/wp\/v2\/deals-cases\/7339","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.millerthomson.com\/fr\/wp-json\/wp\/v2\/deals-cases"}],"about":[{"href":"https:\/\/www.millerthomson.com\/fr\/wp-json\/wp\/v2\/types\/deals-cases"}],"author":[{"embeddable":true,"href":"https:\/\/www.millerthomson.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"version-history":[{"count":0,"href":"https:\/\/www.millerthomson.com\/fr\/wp-json\/wp\/v2\/deals-cases\/7339\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.millerthomson.com\/fr\/wp-json\/wp\/v2\/media?parent=7339"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}